Newcastle biotech firm in £730m deal to develop cancer treatment drug

Share On LinkedIn
Share on X
Newcastle biotech firm in £730m deal to develop cancer treatment drug

Iksuda Therapeutics will get exclusive rights to develop and market LegoChem Biosciences cancer treatment drug

STORY OF THE WEEK

Technology PR, search and social agency

Trending Now

Leave a Reply

Your email address will not be published. Required fields are marked *